Key points are not available for this paper at this time.
A total of 203 smokers "cured" of cancers of the oral cavity, pharynx, or larynx were divided into two groups: those who continued smoking and those who stopped. Within an average follow-up period of approximately seven years, 40% of patients who continued to smoke tobacco developed second cancers in tobacco-contact tissues, whereas 6% of patients who stopped smoking tobacco acquired second cancers. The death rate from second cancers was high; deaths from other causes occurred more often and earlier among the continuing smokers. These results strongly support previous evidence that (1) tobacco plays a major role in cancers of the oral cavity, pharynx, and larynx; and (2) cessation of smoking reduces the risk of second such cancers. Stopping smoking may reduce premature deaths from some other common diseases.
Condict Moore (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: